[3] CMPI's research agenda deals with clinical outcomes and econometric studies that analyze the value of new medicines and genomic and molecular-based medical innovation.
Its officers have written articles on various issues including price controls on pharmaceutical products in publicly funded healthcare schemes in the United States,[4] and restrictions on advertising in the European Union.
The center created a website called BigGovHealth.org to tell the stories of people who faced difficulties with the health care systems in Europe and Canada.
[7][8] The group opposes the importation of drugs in order to lower prices in the United States, arguing in part that Canadian pharmaceutical companies' products are dangerous because they are not regulated by the FDA but by foreign government agencies.
[9] CMPI was founded by Peter Pitts, former FDA Associate Commissioner for External Relations under the Bush administration, and Dr. Robert Goldberg, former fellow at the Manhattan Institute.